Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis.

Cell | Mar 19, 1999

http://www.ncbi.nlm.nih.gov/pubmed/10102272

We have identified the Drosophila transmembrane molecule kekkon 1 (kek1) as an inhibitor of the epidermal growth factor receptor (EGFR) and demonstrate that it acts in a negative feedback loop to modulate the activity of the EGFR tyrosine kinase. During oogenesis, kek1 is expressed in response to the Gurken/EGFR signaling pathway, and loss of kek1 activity is associated with an increase in EGFR signaling. Consistent with our loss-of-function studies, we demonstrate that ectopic overexpression of kek1 mimics a loss of EGFR activity. We show that the extracellular and transmembrane domains of Kek1 can inhibit and physically associate with the EGFR, suggesting potential models for this inhibitory mechanism.

Pubmed ID: 10102272 RIS Download

Mesh terms: Animals | Binding Sites | Calcium-Calmodulin-Dependent Protein Kinases | Drosophila | Drosophila Proteins | Feedback | Gene Expression | Insect Proteins | MAP Kinase Kinase 1 | Membrane Proteins | Mitogen-Activated Protein Kinase Kinases | Nerve Tissue Proteins | Oogenesis | Protein Tyrosine Phosphatases | Protein-Serine-Threonine Kinases | Protein-Tyrosine Kinases | Proto-Oncogene Proteins c-raf | Receptor, Epidermal Growth Factor | Signal Transduction | Transforming Growth Factor alpha | Transforming Growth Factors | ras Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA71702

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.